Its impact exhibits context‐dependent duality: SIRT1 suppresses tumor initiation by promoting DNA repair, genomic stability, and anti‐inflammation during precancerous phases; conversely, it enhances proliferation, survival, and chemoresistance via antiapoptotic effects, metabolic reprogramming, and immunosuppression during progression/metastasis. Here, SIRT1 is linked to neoplasm.